S6E1 - Genetics of Depression and Psychedelic Assisted Therapy

The Psych Review is back in force in 2023, with the entire cast returning for what is shaping up to be an epic season six. In the first episode of this season Dave digs into the largest ever depression focussed genome wide association study and discovers some new significant genetic loci for depression, and Alanna talks us through the recent Therapeutic Goods Administration approval of Psychedelic Assisted Therapies in Australia - a world first.The references for this episode are:Dave: Mitchell, B. L., Campos, A. I., Whiteman, D. C., Olsen, C. M., Gordon, S. D., Walker, A. J., ... & Byrne, E. M. (2022). The Australian Genetics of Depression Study: new risk loci and dissecting heterogeneity between subtypes. Biological Psychiatry, 92(3), 227-235.Alanna: Williams, M. L., Korevaar, D., Harvey, R., Fitzgerald, P. B., Liknaitzky, P., O'Carroll, S., Puspanathan, P., Ross, M., Strauss, N., & Bennett-Levy, J. (2021). Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Frontiers in psychiatry, 12, 737738. https://doi.org/10.3389/fpsyt.2021.737738The Psych Review was brought to you by Call to Mind, a telepsychiatry service that you can learn more about at www.calltomind.com.au. The original music in our podcast was provided by the very talented John Badgery, and our logo was designed by the creative genius of Naz.